News & Press Releases

Mintz attorneys completed a $24.5 million financing in a private placement of common stock and warrants exercisable for common stock on behalf of Neutotrope, Inc., a company focused on developing drugs to treat neurodegenerative diseases including Alzheimer's disease.

Susan M. Finegan, Member of the Litigation Practice and Chair of the Pro Bono Committee at Mintz, has been selected as a 2017 Pinnacle Award winner for outstanding achievement in the professions by the Greater Boston Chamber of Commerce. 

Mintz Special Counsel Ellyn Sternfield is quoted in this Bloomberg BNA Health Care Daily Report article on the final rule from the Department of Health and Human Services Office of Inspector General (OIG).

Alec Zadek of Mintz authored this Massachusetts Lawyers Journal article discussing the Delaware Supreme Court’s ruling in the Cornerstone Therapeutics Inc. case.

Mintz Member Tom Crane is quoted in this Modern Healthcare article discussing the American Hospital Association’s request to President-elect Trump to cancel Stage 3 of the meaningful use program.

ML Strategies' Rodney Whitlock is quoted in this piece from Kaiser Health News regarding the question of whether or not the Center for Medicare & Medicaid Innovation will survive if the ACA is repealed.